These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 18482837)

  • 41. [Design and synthesis of novel PPARgamma agonists].
    Chen T; Jiang B; Guo L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 41(4):700-2. PubMed ID: 20848800
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Computer based design, synthesis and biological evaluation of novel indole derivatives as HCV NS3-4A serine protease inhibitors.
    Ismail NS; El Dine RS; Hattori M; Takahashi K; Ihara M
    Bioorg Med Chem; 2008 Sep; 16(17):7877-87. PubMed ID: 18752958
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Parallel synthesis and biological screening of dopamine receptor ligands taking advantage of a click chemistry based BAL linker.
    Bettinetti L; Löber S; Hübner H; Gmeiner P
    J Comb Chem; 2005; 7(2):309-16. PubMed ID: 15762761
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Computer design of bioactive compounds based on 3-D properties of ligands.
    Martin YC
    NIDA Res Monogr; 1993; 134():84-102. PubMed ID: 8289889
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design, synthesis, and structure-activity relationships of piperidine and dehydropiperidine carboxylic acids as novel, potent dual PPARalpha/gamma agonists.
    Ye XY; Li YX; Farrelly D; Flynn N; Gu L; Locke KT; Lippy J; O'Malley K; Twamley C; Zhang L; Ryono DE; Zahler R; Hariharan N; Cheng PT
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3545-50. PubMed ID: 18511276
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structure-activity relationships of dimeric PPAR agonists.
    Sauerberg P; Mogensen JP; Jeppesen L; Svensson LA; Fleckner J; Nehlin J; Wulff EM; Pettersson I
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1497-500. PubMed ID: 15713415
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design, synthesis, and biological testing of novel naphthoquinones as substrate-based inhibitors of the quinol/fumarate reductase from Wolinella succinogenes.
    Nasiri HR; Madej MG; Panisch R; Lafontaine M; Bats JW; Lancaster CR; Schwalbe H
    J Med Chem; 2013 Dec; 56(23):9530-41. PubMed ID: 24251984
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design and synthesis of novel N-sulfonyl-2-indole carboxamides as potent PPAR-gamma binding agents with potential application to the treatment of osteoporosis.
    Hopkins CR; O'neil SV; Laufersweiler MC; Wang Y; Pokross M; Mekel M; Evdokimov A; Walter R; Kontoyianni M; Petrey ME; Sabatakos G; Roesgen JT; Richardson E; Demuth TP
    Bioorg Med Chem Lett; 2006 Nov; 16(21):5659-63. PubMed ID: 16919947
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 4,4-Dimethyl-1,2,3,4-tetrahydroquinoline-based PPARalpha/gamma agonists. Part. II: Synthesis and pharmacological evaluation of oxime and acidic head group structural variations.
    Parmenon C; Guillard J; Caignard DH; Hennuyer N; Staels B; Audinot-Bouchez V; Boutin JA; Dacquet C; Ktorza A; Viaud-Massuard MC
    Bioorg Med Chem Lett; 2009 May; 19(10):2683-7. PubMed ID: 19376700
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nanosecond molecular dynamics simulations of Cdc25B and its complex with a 1,4-naphthoquinone inhibitor: implications for rational inhibitor design.
    Ko S; Lee W; Lee S; Park H
    J Mol Graph Model; 2008 Aug; 27(1):13-9. PubMed ID: 18359256
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Application of a novel design paradigm to generate general nonpeptide combinatorial templates mimicking beta-turns: synthesis of ligands for melanocortin receptors.
    Webb TR; Jiang L; Sviridov S; Venegas RE; Vlaskina AV; McGrath D; Tucker J; Wang J; Deschenes A; Li R
    J Comb Chem; 2007; 9(4):704-10. PubMed ID: 17429950
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structure-based virtual screening approach to identify novel classes of Cdc25B phosphatase inhibitors.
    Park H; Li M; Choi J; Cho H; Ham SW
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4372-5. PubMed ID: 19500977
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rapid assessment of a novel series of selective CB(2) agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis.
    Ryckmans T; Edwards MP; Horne VA; Correia AM; Owen DR; Thompson LR; Tran I; Tutt MF; Young T
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4406-9. PubMed ID: 19500981
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis of 3-alkyl naphthalenes as novel estrogen receptor ligands.
    Fang J; Akwabi-Ameyaw A; Britton JE; Katamreddy SR; Navas F; Miller AB; Williams SP; Gray DW; Orband-Miller LA; Shearin J; Heyer D
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5075-7. PubMed ID: 18722117
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The natural naphthoquinone plumbagin exhibits antiproliferative activity and disrupts the microtubule network through tubulin binding.
    Acharya BR; Bhattacharyya B; Chakrabarti G
    Biochemistry; 2008 Jul; 47(30):7838-45. PubMed ID: 18597479
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and anti-Trypanosoma cruzi activity of derivatives from nor-lapachones and lapachones.
    da Silva Júnior EN; de Souza MC; Fernandes MC; Menna-Barreto RF; Pinto Mdo C; de Assis Lopes F; de Simone CA; Andrade CK; Pinto AV; Ferreira VF; de Castro SL
    Bioorg Med Chem; 2008 May; 16(9):5030-8. PubMed ID: 18378461
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Resin-bound dynamic combinatorial chemistry.
    McNaughton BR; Miller BL
    Org Lett; 2006 Apr; 8(9):1803-6. PubMed ID: 16623555
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular conceptor for training in medicinal chemistry, drug design, and cheminformatics.
    Cohen C; Fischel O; Cohen E
    Chem Biol Drug Des; 2007 Jan; 69(1):75-82. PubMed ID: 17313460
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recent developments in de novo design and scaffold hopping.
    Mauser H; Guba W
    Curr Opin Drug Discov Devel; 2008 May; 11(3):365-74. PubMed ID: 18428090
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design and synthesis of novel oxazole containing 1,3-dioxane-2-carboxylic acid derivatives as PPAR alpha/gamma dual agonists.
    Pingali H; Jain M; Shah S; Makadia P; Zaware P; Goel A; Patel M; Giri S; Patel H; Patel P
    Bioorg Med Chem; 2008 Aug; 16(15):7117-27. PubMed ID: 18625559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.